Financial Symmetry Inc
Position in PVCT — Provectus Biopharmaceuticals, Inc.
CIK 2004843
RALEIGH, NC
Position in PVCT
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$703
+$184 QoQ
Shares Held
10,191
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 3 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PVCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Financial Symmetry Inc holds $378,217 across 2 Biotechnology names. PVCT ranks #2 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
760 | $377,514 | |
| 2 | PVCT |
Provectus Biopharmaceuticals, Inc.
This page
|
10,191 | $703 |
All Filings in PVCT
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $703 | 10,191 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $519 | 10,191 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $570 | 10,191 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $906 | 10,191 | Shares | Sole | 2025-12-17 | |
| 2025-06-30 | $764 | 10,191 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,019 | 10,191 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,222 | 10,191 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $998 | 10,191 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,284 | 10,191 | Shares | Sole | 2024-07-10 | |
| 2023-12-31 | $978 | 10,191 | Shares | Sole | 2024-01-31 | |
| No filing history on record for this holder in this stock. | ||||||